These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1613700)

  • 21. Treatment of intraventricular hemorrhage with intraventricular administration of recombinant tissue plasminogen activator A clinical study of 18 cases.
    Vereecken KK; Van Havenbergh T; De Beuckelaar W; Parizel PM; Jorens PG
    Clin Neurol Neurosurg; 2006 Jul; 108(5):451-5. PubMed ID: 16139422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cold stimulus fingertip lacticemy test--an effective method to monitor acute therapeutic intervention on primary Raynaud's phenomenon and systemic sclerosis.
    Fontenelle SM; Kayser C; Pucinelli ML; Andrade LE
    Rheumatology (Oxford); 2008 Jan; 47(1):80-3. PubMed ID: 18077495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
    Abou-Raya A; Abou-Raya S; Helmii M
    J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant tissue-type plasminogen activator as a thrombolytic agent in acute myocardial infarction.
    Parr KL; Valentine RP; Pitts DE; Schumacher RR; Schmidt PE; Brooks-Brunn JA; Ramsden C
    Indiana Med; 1987 May; 80(5):460-1. PubMed ID: 2953781
    [No Abstract]   [Full Text] [Related]  

  • 25. [Blood pressure of the fingers of patients with progressive systemic sclerosis].
    Mizutani H; Hattori T; Shimizu M; Hamaguchi T
    Nihon Hifuka Gakkai Zasshi; 1984 Aug; 94(9):1015-20. PubMed ID: 6513092
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE study.
    Hachulla E; Hatron PY; Carpentier P; Agard C; Chatelus E; Jego P; Mouthon L; Queyrel V; Fauchais AL; Michon-Pasturel U; Jaussaud R; Mathian A; Granel B; Diot E; Farge-Bancel D; Mekinian A; Avouac J; Desmurs-Clavel H; Clerson P;
    Ann Rheum Dis; 2016 Jun; 75(6):1009-15. PubMed ID: 25995322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The safety and efficacy of low-dose tissue plasminogen activator in the treatment of systemic sclerosis.
    Wilson D; Edworthy SM; Hart DA; Fritzler MJ
    J Dermatol; 1995 Sep; 22(9):637-42. PubMed ID: 8537548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of sclerosis treatment based on blood circulation or vascular lesions].
    Takeda K; Shigemi F; Shiraishi S; Nagai T; Kuwabara A
    Nihon Hifuka Gakkai Zasshi; 1977 Nov; 87(12):778-81. PubMed ID: 304924
    [No Abstract]   [Full Text] [Related]  

  • 29. Management of the hand in systemic sclerosis.
    Fox P; Chung L; Chang J
    J Hand Surg Am; 2013 May; 38(5):1012-6; quiz 1017. PubMed ID: 23561724
    [No Abstract]   [Full Text] [Related]  

  • 30. Prolonged healing of malleolar ulcers after fibrinolytic treatment in a woman with systemic sclerosis.
    Ames PR; Stephens JW; Steuer A; Gumpel JM
    Br J Rheumatol; 1998 Jan; 37(1):107-9. PubMed ID: 9487264
    [No Abstract]   [Full Text] [Related]  

  • 31. Neural blockade, urokinase and prostaglandin E1 combination therapy for acute digital ischemia of progressive systemic sclerosis.
    Shimizu Y; Mizutani H; Inachi S; Tsuchibashi T; Shimizu M
    J Dermatol; 1994 Oct; 21(10):755-9. PubMed ID: 7798434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skin perfusion of fingers shows a negative correlation with capillaroscopic damage in patients with systemic sclerosis.
    Rosato E; Giovannetti A; Pisarri S; Salsano F
    J Rheumatol; 2013 Jan; 40(1):98-9. PubMed ID: 23280170
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immediate results of long-term treatment of systemic scleroderma with leukeran].
    Olszewska Z
    Reumatologia; 1978; 16(2):259-66. PubMed ID: 358343
    [No Abstract]   [Full Text] [Related]  

  • 34. A pilot study of cutaneous oxygenation and perfusion in systemic sclerosis-related digital calcinosis.
    Manning JB; Marjanovic E; Moore TL; Dinsdale G; Wilkinson S; Dickinson MR; Herrick AL; Murray AK
    Rheumatology (Oxford); 2020 Oct; 59(10):3109-3111. PubMed ID: 32259842
    [No Abstract]   [Full Text] [Related]  

  • 35. Experimentally controlled evaluation of vasoactive drugs in digital ischemia.
    Holti G
    Angiology; 1978 Jan; 29(1):89-94. PubMed ID: 343655
    [No Abstract]   [Full Text] [Related]  

  • 36. A placebo-controlled study on urokinase therapy in systemic sclerosis.
    Ciompi ML; Bazzichi L; Melchiorre D; De Giorgio F; Bondi F; Puccetti L
    Biomed Pharmacother; 1996; 50(8):363-8. PubMed ID: 8952856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ketanserin: an effective treatment regimen for digital ischaemia in systemic sclerosis.
    Klimiuk PS; Kay EA; Mitchell WS; Taylor L; Gush R; Gould S; Jayson MI
    Scand J Rheumatol; 1989; 18(2):107-11. PubMed ID: 2734594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Failure of low molecular weight dextran infusions in scleroderma.
    Kirk JA; Dixon AS
    Ann Rheum Dis; 1969 Jan; 28(1):49-54. PubMed ID: 5786283
    [No Abstract]   [Full Text] [Related]  

  • 39. Ketanserin in the treatment of progressive systemic sclerosis.
    Altomare GF; Pigatto PD; Polenghi MM
    Angiology; 1988 Jul; 39(7 Pt 1):583-6. PubMed ID: 3408023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant tissue plasminogen activator for the treatment of cutaneous infarctions in antiphospholipid antibody syndrome: a case report.
    Srinivasan SK; Pittelkow MR; Cooper LT
    Angiology; 2001 Sep; 52(9):635-9. PubMed ID: 11570663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.